Business - Briefly   

Strides Arcolab ties up with U.S. firm

NEW DELHI: Strides Arcolab has signed a non-exclusive licence and technical transfer agreement with the U.S.-based bio-pharmaceutical company, Gilead Sciences. The agreement will enable the company to manufacture and distribute generic versions of Truvada and Vlread drugs. It also provides for the manufacture and distribution of a new generation first line therapy in over 90 countries under the Gilead Access Programme.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

NeST group targets $1-billion enterprise value
Tuticorin port's initiative to woo cargo
`Buy options to check wheat price'
Kelvinator targets 10 per cent market share in State
Sensex zooms 135 points on funds buying
M&M to make `Ingenio' platform
Rupee recovers against dollar
IDBI to introduce new deposit scheme
Andhra Bank, ICICI Bank lead in NPA cut: study
ONGC unit to restart operations
Maples ESM plans centre in Japan
Amara Raja's expansion plan
Exchange rates
Bullion rates
Kumar Mangalam Birla resigns from Tata Steel
IFAC exposure draft on IT
GMR, Tech Mahindra to list on Aug. 21, 29
Norms for schools, houses in SEZs soon
Bennett, Coleman takes stake in insurance JV
Bharat Yantra Nigam to be closed down
Arcelor Mittal makes changes in U.S. division
Swaraj Mazda in alliance with Isuzu
FireStream acquires TMI Services
Strides Arcolab ties up with U.S. firm
UTI Mid Cap Fund declares 30 p.c.
Ybrant Technologies facility in Hyderabad

Copyright © 2006, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu